References
- Amy J. J., Karim S. M.M. “Intrauterine administration of 1-noradrenaline and propranolol during the second trimester of pregnancy”. Br. J. Obstet. Gynaecol. 1974; 81: 75–83
- Barden T. P., Stander R. W. “Myometrial and cardiovascular effects of an adrenergic blocking drug in human pregnancy”. Am. J. Obstet. Gynecol. 1968; 101: 91–99
- Department of Health and Social Security. Report on Confidential Inquiry into Maternal Deaths in England and Wales 1973-1975. HMSO, London 1979
- Edwards R. C., Raftery E. P. “Haemodynamic effects of long term oral labetalol”. Br. J. Clin. Pharmacol 1976; 3, (Suppl), 733
- Lamming G. D., Pipkin F. B., Symonds E. M. “Comparison of the alpha- and beta-blocking drug, labetalol, and methyl dopa in the treatment of moderate and severe pregnancy induced hypertension”. Clin. Exp. Hypertens 1980; 2(5)865–895
- Lardoux H., Gerard J., Blazquez G., Chouty F., Flouvat B. “Hypertension in pregnancy: evaluation of two beta blockers atenolol and labetalol”. Eur. Heart J. 1983; 4: 35–40, (Suppl. G)
- Lunell N. O., Fredholm B., Hjemdahl P. “Labetalol, a combined alpha- and beta- blocker in hypertension of pregnancy”. Acta Med. Scand. 1982; 665: 143–147, (Suppl
- MacCarthy E. P., Bloomfield S. S. “Labetalol: a review of it's pharmacology, pharmacokinetics, clinical uses and adverse effects”. Pharmacotherapy 1983; 3(4)193–219
- MacGillivray I. Pre-eclampsia, the Hypertensive Disease of Pregnancy. W.B. Saunders Co. Ltd. 1983
- Michael C. A. “Use of labetalol in the treatment of severe hypertension during pregnancy”. Br. J. Clin. Pharmacol. 8 (Suppl) 1979; 3: 2115–2155
- Michael C. A., Potter J. M. “A comparison of labetalol with anti-hypertensive drugs in the treatment of hypertensive disease of pregnancy. Investigation of Labetalol in the Management of Hypertension in Pregnancy, A. Riley, E. M. Symonds. International Congress Series 591, Excerpta Medica, Amsterdam 1982; 111
- Nylund L., Lunnell N. O., Lewander R., Sarby B., Thornstrom S. “Labetalol for the treatment of hypertension in pregnancy”. Pharmacokinetics and effects on the uteroplacental blood flow. Acta Obstet. Gynecol. Scand. (Suppl) 1984; 118: 71–73
- Pickles C. J., Symonds E. M., Broughton-Pipkin F. “The fetal outcome in a randomised double-blind controlled trial of labetalol versus placebo in pregnancy-induced hypertension.”. Br J Obstet Gynaecol 1989; 96: 38–43
- Sibai B. M., Gonzalez A. R., Mabie W. C., Moretti M. “A comparison of labetalol plus hospitalisation versus hospitalisation alone in pre-elcampsia remote from term”. Obstet Gynecol 1987; 70: 323–327
- Wollam K. C., Cody P. R., Tarazi R. C., Bravo E. L. “Acute haemodynamic effect and cardioselectivity of acebutalol, practolol and propranolol. Clin. Pharmac. Therapeut. 1979; 25: 813